The German Liver Foundation has highlighted that travel to various tourist destinations may pose a risk for infections of viral hepatitis, particularly hepatitis A and hepatitis B. Hepatitis A viruses are primarily transmitted through contaminated food and water, leading to symptoms that resemble those of influenza, including fever, nausea, vomiting, abdominal pain, and general malaise.

Additionally, a symptom of hepatitis A is jaundice, which manifests as yellowing of the skin and the whites of the eyes; this has led to hepatitis A being colloquially referred to as 'traveler's jaundice.' Typically, the infection resolves without complications, although liver damage may persist.

Hepatitis B viruses are transmitted through body fluids such as blood, saliva, semen, or vaginal secretions.

Infection can also occur through the sharing of personal items such as razors, needles, toothbrushes, or sexual intercourse.

Hepatitis B may cause inflammation of the liver, with symptoms mirroring those of influenza, and it can develop into a chronic condition.

Chronic hepatitis B could subsequently lead to secondary illnesses such as cirrhosis or liver cancer.

To prevent hepatitis infections, individuals are advised to review their vaccination status against hepatitis and receive vaccinations when necessary, ideally six to eight weeks prior to travel.

Vaccination against hepatitis A is recommended for travel to Central and South America, Africa, Asia, and Eastern European countries.

Vaccination against hepatitis B is advised for travel longer than four weeks or when planning surgical or dental procedures in the destination country.

Additionally, there are combination vaccines available that protect against both hepatitis A and B.